Comparison of long-term results of transurethral incision of the prostate with transurethral resection of the prostate, in patients with benign prostatic hypertrophy

The clinical effectiveness of transurethral incision of the prostate: a systematic review of randomised controlled trials

“…We assessed full-text copies of 621 published articles concerning TURP and TUIP to yield 10 RCTs meeting inclusion criteria for the review which were published in 14 reports and described outcome in 795 men recruited between 1985 and 1991, 392 of whom underwent TUIP and 403 TURP [10][11][12][13][14][15][16][17][18][19][20][21][22]. An upper limit of prostate size was explicitly stated as an entry criterion for eight studies with five < 30 ml and three < 60 ml.…”

“…IPSS and AUA scores were considered equivalent and therefore trials using these instruments were combined. The IPSS/AUA symptom questionnaire asks men to rate four voiding symptoms (poor stream, intermittent flow, straining, incomplete emptying) and three storage symptoms (frequency, nocturia, urgency) on a scale from 0 (not present) to 5 (severe) to give a total score ranging from 0 to 35, with symptom severity defined as: mild (0-7), moderate (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19) or severe (20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35). With Madsen-Iversen scores, patients are rated in terms of the quality of their urinary stream, straining to void, hesitancy, intermittency, bladder emptying, stress incontinence or post void dribbling, urgency, frequency, and nocturia on a scale from 0 to 4 to give a total score ranging from 0 to 27, with symptom severity defined as: mild (<10), moderate (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20) or severe (>20).…”

Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO.it

“…QoL and symptom improvements with transurethral incision of the prostate (TUIP) have been shown in randomised trials (average prostatic weight approximately 30 g) to be not significantly different to those with monopolar TURP [Tkocz and Prajsner, 2002;Larsen et al 1987;Dørflinger et al 1992;Riehmann et al 1995;Saporta et al 1996;Jahnson et al 1998]. Intra-and postoperative complication rates with TUIP are generally similar to those with TURP; reintervention rate is significantly higher with TUIP than with TURP, while ejaculatory dysfunction is significantly lower [Lourenco et al 2010].…”

Consideration of Drug Therapy in Benign Prostatic Hypertrophy

“…Sometimes useful PSA density (PSA Secic / prostate volume > 0,15), PSA velocity (increases greater than or equal to 0,75 mg/ml/year correlated with age -the serum level increases with age) [11,12]. PSA and the amount of the prostate can be used as parameters of the evaluation of the natural history of benign prostatic hyperplasia, a risk of urinary retention or surgery [13,14,15].…”